GSK’s Shingrix Prefilled Syringe Approved in Japan for Shingles Prevention
GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a prefilled syringe presentation of Shingrix (Recombinant Zoster Vaccine, RZV) for the prevention of shingles (herpes zoster). The announcement was made on September 10, 2026.





















